PeptideDB

Anticancer agent 139

CAS No.:

Compound 6h (Anticancer Agent 139) exhibits potent anticancer activity, engaging in a π-cationic interaction with Lys35
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Compound 6h (Anticancer Agent 139) exhibits potent anticancer activity, engaging in a π-cationic interaction with Lys352 of Tubulin and demonstrating high efficacy against SNB-19, OVCAR-8, and NCI-H460 with PGIs of 86.61, 85.26, and 75.99, respectively. Moreover, it shows moderate activity against a range of other cancer cell lines — HOP-62, SNB-75, ACHN, NCI/ADR-RES, 786-O, A549/ATCC, HCT-116, and MDA-MB-231 — with PGIs between 51.88 and 67.55 [1].
molecular weight 319.28
Molecular formula C16H12F3N3O
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year